Abstract:Objective To observe the effects of endoscopic drug therap on hemostasis, re-bleeding and the risk of occurrence of complication in patients with acute esophageal and gastric variceal bleeding (EGVB). Methods A retrospective method was conducted, and 100 patients with EGVB who were admitted to the Affiliated Hospital of Yan'an University from June 2015 to June 2017 were enrolled. According to the difference in treatment methods, they were divided into an endoscopy Sclerotherapy and Ligation group and transjugular intrahepatic portosystemic shunt (TIPS) group, 50 cases in each group. The TIPS group was treated with TIPS; the endoscopy Sclerotherapy and Ligation group underwent endoscopic variceal sclerotherapy, endoscopic esophageal variceal ligation and postoperative non-selective β blockers oral administration. After 2 years of follow-up, the patients' hemostasis, re-bleeding at acute stage, survival situation and the incidences of complications were recorded. Before treatment and 2 weeks after treatment, the levels of serum albumin (Alb), total bilirubin (TBil) and platelet count (PLT) were measured by Hitachi automatic biochemical analyzer in the two groups. Results The success rate of hemostasis in the endoscopy Sclerotherapy and Ligation group was significantly higher than that in the TIPS group [98.0% (49/50) vs. 82.0% (41/50) ], and the recurrence rate of varices, during 1- and 2-year follow-up, the recurrence rate of bleeding and the incidences of complications were significantly lower than those in TIPS group [the recurrence rate of varicose veins: 6.0% (3/50) vs. 24.0 (12/50), 1-year re-bleeding rate: 12.0% (6/50) vs. 30.0% (15/50), 2-year re-bleeding rate: 42.0% (21/50) vs. 66.0% (33/50), esophageal ulcer: 2.0% (1/50) vs. 14.0% (7/50), upper abdominal discomfort: 2.0% (1/50) vs. 14.0% (7/50), hepatic encephalopathy:4.0% (2/50) vs. 16.0% (8/50), chest pain: 6.0% (3/50) vs. 20.0% (10/50), all P < 0.05]. After treatment, the levels of Alb and PLT in the endoscopy Sclerotherapy and Ligation group were higher than those in the TIPS group [Alb (g/L):43.84±4.34 vs. 40.83±3.21, PLT (×109/L): 26.33±3.37 vs. 21.12±3.89, both P < 0.05], and the TBil was lower than that in the TIPS group (μmol/L: 13.82±4.32 vs. 19.33±4.59). Conclusion Endoscopic Sclerotherapy and Ligation can significantly improve the effect of hemostasis of patients with acute EGVB, the rate of re-bleeding does not increase compared with that of western medicine group using TIPS, and the incidences of complications are significantly lower than those of applying TIPS.

[Endoscopic Sclerotherapy of Gastric Varices by Tissue Adhesives].

[Use of Endoscopic Tissue Adhesive Injection for Gastric Varices].

Sa1476 Clinical Characteristics and Outcomes of Gastric Varices Subtypes in Patients Treated with Endoscopic Injection of Tissue Adhesives

The study of effect on portal hypertensive gastropathy after treating gastric varices by endoscopic injection of tissue adhesive

The Clinical Value of Endoscopic Injection of Tissue Adhensive for Gastric Varices Bleeding

Esophageal Variceal Ligation Monotherapy Versus Combined Ligation and Sclerotherapy for the Treatment of Esophageal Varices.

Gastric Varices Bleeding Treated by Tissue Adhesive, D-TH Glue Injection

Endoscopic band ligation or endoscopic tissue adhesive injection in the treatment of gastric varices: Which is better?

Advances in the endoscopic management of gastric varices

Influencing Factors and Efficacy of Endoscopic Tissue Adhesives Injection in Preventing Esophageal Gastric Varices Bleeding

Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices: a randomized pilot study.

Tissue Adhesive N- Oclyl- Α - Cyanoacrylate Injection for Homeostasis of Esophagogastric Varices Bleeding

Esophageal and Gastric Varices in Patients with Liver Cirrhosis: Curative Effect of Endoscopic Injection of Polidocanol and Tissue Adhesive

Clinical evaluation of different modalities in emergency endoscopic treatment of esophageal variceal bleeding

Endoscopic devices and techniques for the management of gastric varices (with videos)

Transparent cap-assisted endoscopic sclerotherapy in esophageal varices: a randomized-controlled trial.

Clinical therapeutic effects of endoscopic drug therapy for treatment of patients with acute esophageal and gastric variceal bleeding

A retrospective analysis of the efficacy of endoscopic variceal ligation versus endoscopic tissue adhesive injection in the treatment of esophagogastric variceal bleeding

Short-term efficacy and safety of endoscopic injection of low dose of sclerotherapy and cyanoacrylate injection for type GOV1 gastric varices combined with endoscopic variceal ligation for esophageal varices

Sa1047 Efficacy of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices

Histoacryl-NS fluid treatment of esophageal gastric varices and its bleeding